A comparison of observational studies and controlled trials of heparin in ulcerative colitis

International Journal of Clinical Pharmacology and Therapeutics

Volumn 42, Issue 12, 2004, Pages 690-694

  Malhotra, S ^a   Kondal, A ^a   Shafiq, N ^a   Sidhu, S ^a   Bhasin, D K ^a   Pandhi, P ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Controlled clinical trials; Heparin; Meta analysis; Observational studies; Ulcerative colitis

Indexed keywords

DALTEPARIN; ENOXAPARIN; GLUCOCORTICOID; HEPARIN; HYDROCORTISONE; LOW MOLECULAR WEIGHT HEPARIN; MESALAZINE; METHYLPREDNISOLONE; NADROPARIN; PREDNISOLONE; SALAZOSULFAPYRIDINE;

ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; DRUG EFFICACY; HUMAN; INTERMETHOD COMPARISON; MEDLINE; META ANALYSIS; STATISTICAL MODEL; TYPES OF STUDY; ULCERATIVE COLITIS;

EID: 10344256686     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP42690     Document Type: Article

References (21)

1. D'Agostino HB, Weintraub M 1995 Meta-analysis: a method for synthesizing research. Clin Pharmacol Ther 58: 605-616
2. Ang YS, Mahmud N, White B, Byrne M, Kelly A, Lawler M 2000 Randomized comparison of unfractionated heparin with corticosteroids in severe active inflammatory bowel disease. Aliment Phan-nacol Ther 14: 1015-1022
3. Chalmers TC, Smith H jr, Blackburn B, Silverman B, Shroeder B, Reitman D et al 1981 Amethod for assessing the quality of a randomized controlled trial. Controlled Clin Trial 2: 231-249
4. Day R, Forbes A 1999 Heparin, cell adhesion and pathogenesis of inflammatory bowel disease. Lancet 354: 62-65
5. Dofan I, Hallak A, Arher N, Santo M, Alexandrowitz A, Knaani Y et al 2001 Low dose low molecular weight heparin (enoxaparin) is effective as adjuvant treatment in active ulcerative colitis: an open trial. Dig Dis Sci 46: 2239-2244
6. Evans RC, Wong VS, Morris AI, Rhodes JM 1997 Treatment of corticosteroid-resistant ulcerative colitis with heparin - a report of 16 cases. Aliment Pharmacol Ther 11: 1037-1040
7. Folivaczny C, Wiebecke B, Loesctike K 1999 Unfractionated heparin in the therapy of patients with highly active inflammatory bowel disease. Am J Gastroenterol 94: 1551-1555
8. Gaffney PR, Doyle CT, Gaffney A, Hogan J, Hayes DP, Annis P 1995 Paradoxical response to heparin in 10 patients with ulcerative colitis. Am J Gastroenterology 90: 220-223
9. Glukman RM 2001 Inflammatory bowel disease. In: Fauci AS, Brauawal E, Isselbacher KJ et al (eds): Harrison's Principles of Internal Medicine. 15th ed. Mc Graw-Hill, New York, pp 1682-1690
10. Koenig A, Norgard SK, Linhardt R, Varki A 1998 Differential interactins of heparin and heparin sulfate glycosaminoglycans with the selectins implications for the use of unfractionated and low molecular weight heparins as therapeutic agents. J Clin Invest 101: 877-889
11. Malhotra S, Bhargava VK, Grover A, Pandhi P, Sharma YP 2001 A randomized trial to compare the efficacy, safety, cost and platelet aggregating effects of enoxaparin and unfractionated heparin. The ESCAPEU trial. Int J Clin Phar Ther 39: 110-115
12. Mathews KA, Kuller LH, Wing RR, Meilahn LN, Plantinga P 1996 Prior to use of estrogen replacement therapy, are users healthier than non-users? Am J Epidemiol 143: 971-978
13. Miser WF 2001 Applying a meta-analysis to daily clinical practice. In: Geryman JP, Deyo RA, Ramsay SD (eds): Evidence based clinical practice. Butterworth-Helineman, Wobourn, pp 57-64
14. Panes J, Esteve M, Cabre E, Hinojosa J, Andreu M, Sans M 2000 Comparison of heparin and steroids in the treatment of moderate and severe ulcerative colitis. Gastroenterol 119: 903-908
15. Salas A, Sans M, Soriano A, Reverter JC, Anderson DC, Pique JW et al 2000 Heparin alternates TNFα-induced inflammatory response through a CDIIb-dependent mechanism. Gut 47: 88-96
16. Sands BE 2000 Therapy of inflammatory bowel disease. Gastroenterology 118: S68-S82
17. Torkvist L, Thorlacius H, Sjoqvist U, Bohman L, Lapidus A, Flood L et al 1999 Low molecular weight heparin as adjuvant therapy in active ulcerative colitis. Aliment Pharmacol Ther 13: 1323-1328
18. Vrij AA, Jansen JM, Schoon EJ, de Bruine A, Hemker HC, Stockbrugger RW 2001 Low molecular weight heparin treatment in steroid refractory ulcerative colitis: clinical outcome and influence on mucosal capillary thrombi. Scand J Gastroenterol (Suppl) 23: 41-47
19. www.aafp.org/afp/20000101/tips/17html Sadovskyh: Recent analysis of hormone replacement therapy
20. Zahernakowa TV, Kashmenskaya NA, Maltseva JV 1984 Hemostasis and heparin therapy in non-specific ulcerative colitis. Soviet Med (Moskva) 2: 110-113
21. Zargonodniy LG, Mustyats AP 1982 The use of anticoagulants in combined therapy of non-specific ulcerative colitis. Klin Med (Moskva) 60: 74-80